BGA BioNeutra Global Corporation
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, European Union, and the Asia Pacific. The company is headquartered in Vancouver, Canada.…
Industry Peers
Packaged FoodsKey Statistics
About BioNeutra Global (CVE: BGA)
›
BioNeutra Global (CVE: BGA) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector.
The shares were at 0.0300 CAD on 18 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 0.0300 CAD to 0.0300 CAD, and it trades at the top of that range.
Its market capitalisation is 1.39M CAD.
BioNeutra Global reports return on equity of 34.0%, an operating margin of -7.4% and revenue up 20.3% year over year.
Its debt exceeds its cash by 6.75M CAD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health.